East Midlands Charcot Incidence Study (EMCIS)
Research type
Research Study
Full title
PROSPECTIVE STUDY OF THE IMPACT AND COST OF CHARCOT INFLAMMATORY OSTEOARTHROPATHY OF THE FOOT IN DIABETES IN THE EAST MIDLANDS
IRAS ID
234956
Contact name
William Jeffcoate
Contact email
Sponsor organisation
Nottingham University Hospitals NHS Trust
Duration of Study in the UK
1 years, 5 months, 30 days
Research summary
The Charcot foot is an uncommon complication of nerve damage (neuropathy) in people with diabetes. It is characterised by inflammation of the foot with varying degrees of damage to the bones and joints, including fractures and dislocations that can lead to a very deformed foot. The consequences to patients include a high risk of limb loss, and it is also associated with poor life expectancy.
Although the condition is well described clinically, no previous attempt has been made to assess its incidence in a well defined population. Similarly, although the enormous cost of diabetic foot ulcers is well documented and is estimated to be approximately £1 billion per annum (and thus represents approximately 0.8% total NHS budget), there has been no previous attempt made to assess the cost of the Charcot foot in diabetes.REC name
North East - Newcastle & North Tyneside 1 Research Ethics Committee
REC reference
17/NE/0376
Date of REC Opinion
5 Dec 2017
REC opinion
Favourable Opinion